386 filings
Page 4 of 20
8-K
l5e2y8vz31gw7uzu1x1
7 Nov 18
Melinta Therapeutics Reports Third Quarter 2018 Financial Results
8:27am
8-K
4y7pv
5 Nov 18
Departure of Directors or Certain Officers
5:21pm
8-K
3zqgyjx9 z53gvp6lq
24 Oct 18
Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer
4:59pm
8-K
tu6rzz
5 Oct 18
Departure of Directors or Certain Officers
5:18pm
8-K
5ud5sv
2 Oct 18
Entry into a Material Definitive Agreement
4:55pm
8-K
009fp4vq
27 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
l6219 00zm3sp7w24d
19 Sep 18
Melinta Therapeutics Names Peter Milligan as Chief Financial Officer
9:23am
S-8
jdqd isobd8jmdhp1uf
4 Sep 18
Registration of securities for employees
12:00am
S-8
dg9hl2gt
4 Sep 18
Registration of securities for employees
12:00am
8-K
y6wmk3v
7 Aug 18
Melinta Therapeutics Reports Second Quarter 2018 Financial Results
9:15am
8-K
lrga 7emah26xnpo3oa
14 Jun 18
Departure of Directors or Certain Officers
12:00am
CT ORDER
rxptusokm3l7
11 Jun 18
Confidential treatment order
12:00am
8-K/A
r1hga
8 Jun 18
Financial Statements and Exhibits
4:39pm
8-K
iwv1tapf
29 May 18
Melinta Therapeutics Announces Proposed Offering of Common Stock
5:18pm
424B5
e3uh o6sge64
25 May 18
Prospectus supplement for primary offering
6:09am
FWP
09w2zk m1a
21 May 18
Free writing prospectus
4:13pm
424B5
c29t9 gzs
21 May 18
Prospectus supplement for primary offering
4:04pm